As of 2024-12-14, the Relative Valuation of CureVac NV (CVAC) is 7.87 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.16 USD, the upside of CureVac NV based on Relative Valuation is 149.1%.
The range of the Relative Valuation is 7.46 - 8.57 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 15.4x | 15.0x |
| Forward P/E multiples | 15.1x - 16.9x | 16.0x |
| Fair Price | 7.46 - 8.57 | 7.87 |
| Upside | 136.2% - 171.1% | 149.1% |
| Date | P/E |
| 2024-12-13 | 6.23 |
| 2024-12-12 | 6.31 |
| 2024-12-11 | 6.44 |
| 2024-12-10 | 6.33 |
| 2024-12-09 | 6.65 |
| 2024-12-06 | 6.11 |
| 2024-12-05 | 6.00 |
| 2024-12-04 | 5.70 |
| 2024-12-03 | 5.62 |
| 2024-12-02 | 5.76 |
| 2024-11-29 | 5.66 |
| 2024-11-27 | 5.66 |
| 2024-11-26 | 5.40 |
| 2024-11-25 | 5.46 |
| 2024-11-22 | 5.25 |
| 2024-11-21 | 5.05 |
| 2024-11-20 | 4.91 |
| 2024-11-19 | 4.93 |
| 2024-11-18 | 5.09 |
| 2024-11-15 | 5.01 |
| 2024-11-14 | 5.27 |
| 2024-11-13 | 5.42 |
| 2024-11-12 | 5.68 |
| 2024-11-11 | 5.50 |
| 2024-11-08 | 5.60 |
| 2024-11-07 | 5.58 |
| 2024-11-06 | 5.64 |
| 2024-11-05 | 5.78 |
| 2024-11-04 | 5.35 |
| 2024-11-01 | 5.44 |
| 2024-10-31 | 5.40 |
| 2024-10-30 | 5.52 |
| 2024-10-29 | 5.70 |
| 2024-10-28 | 5.58 |
| 2024-10-25 | 5.42 |
| 2024-10-24 | 5.37 |
| 2024-10-23 | 5.33 |
| 2024-10-22 | 5.42 |
| 2024-10-21 | 5.46 |
| 2024-10-18 | 5.52 |
| 2024-10-17 | 5.56 |
| 2024-10-16 | 5.60 |
| 2024-10-15 | 5.54 |
| 2024-10-14 | 5.56 |
| 2024-10-11 | 5.74 |
| 2024-10-10 | 5.66 |
| 2024-10-09 | 5.74 |
| 2024-10-08 | 5.70 |
| 2024-10-07 | 5.88 |
| 2024-10-04 | 5.96 |